United States Diabetic Macular Edema Market Research Report Forecast 2017 to 2022
Delivery of the Report will take 2-3 working days once order is placed.
The United States Diabetic Macular Edema Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Diabetic Macular Edema industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Diabetic Macular Edema market study provides comprehensive data which enhances the understanding, scope and application of this report.
This report provides comprehensive analysis of
Birken AG
Stratatech Corporation
Fibrocell Science, Inc.
GlaxoSmithKline Plc
InMed Pharmaceuticals Inc.
Karus Therapeutics Limited
RegeneRx Biopharmaceuticals, Inc..
Scioderm, Inc.
Shire Plc
United States Diabetic Macular Edema Market: Product Segment Analysis
Type 1
Type 2
Type 3
United States Diabetic Macular Edema Market: Application Segment Analysis
Application 1
Application 2
Application 3
Reasons for Buying this Report
The United States Diabetic Macular Edema Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Diabetic Macular Edema industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Diabetic Macular Edema market study provides comprehensive data which enhances the understanding, scope and application of this report.
This report provides comprehensive analysis of
- Key market segments and sub-segments
- Evolving market trends and dynamics
- Changing supply and demand scenarios
- Quantifying market opportunities through market sizing and market forecasting
- Tracking current trends/opportunities/challenges
- Competitive insights
- Opportunity mapping in terms of technological breakthroughs
Birken AG
Stratatech Corporation
Fibrocell Science, Inc.
GlaxoSmithKline Plc
InMed Pharmaceuticals Inc.
Karus Therapeutics Limited
RegeneRx Biopharmaceuticals, Inc..
Scioderm, Inc.
Shire Plc
United States Diabetic Macular Edema Market: Product Segment Analysis
Type 1
Type 2
Type 3
United States Diabetic Macular Edema Market: Application Segment Analysis
Application 1
Application 2
Application 3
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a six-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
CHAPTER 1 DIABETIC MACULAR EDEMA MARKET OVERVIEW
1.1 Product Overview and Scope of Diabetic Macular Edema
1.2 Diabetic Macular Edema Market Segmentation by Type
1.2.1 United States Production Market Share of Diabetic Macular Edema by Type in 2016
1.2.1 Type
1.2.2 Type
1.2.3 Type
1.3 Diabetic Macular Edema Market Segmentation by Application
1.3.1 Diabetic Macular Edema Consumption Market Share by Application in 2016
1.3.2 Application
1.3.3 Application
1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Diabetic Macular Edema (2011-2021)
CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON DIABETIC MACULAR EDEMA INDUSTRY
2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend
CHAPTER 3 UNITED STATES DIABETIC MACULAR EDEMA MARKET COMPETITION BY MANUFACTURERS
3.1 United States Diabetic Macular Edema Production and Share by Manufacturers (2015 and 2016)
3.2 United States Diabetic Macular Edema Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Diabetic Macular Edema Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Diabetic Macular Edema Manufacturing Base Distribution, Production Area and Product Type
3.5 Diabetic Macular Edema Market Competitive Situation and Trends
3.5.1 Diabetic Macular Edema Market Concentration Rate
3.5.2 Diabetic Macular Edema Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
CHAPTER 4 UNITED STATES DIABETIC MACULAR EDEMA PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 United States Diabetic Macular Edema Production and Market Share by Type (2012-2017)
4.2 United States Diabetic Macular Edema Revenue and Market Share by Type (2012-2017)
4.3 United States Diabetic Macular Edema Price by Type (2012-2017)
4.4 United States Diabetic Macular Edema Production Growth by Type (2012-2017)
CHAPTER 5 UNITED STATES DIABETIC MACULAR EDEMA MARKET ANALYSIS BY APPLICATION
5.1 United States Diabetic Macular Edema Consumption and Market Share by Application (2012-2017)
5.2 United States Diabetic Macular Edema Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
5.3.1 Potential Applications
5.3.2 Emerging Markets/Countries
CHAPTER 6 UNITED STATES DIABETIC MACULAR EDEMA MANUFACTURERS ANALYSIS
6.1 Birken AG
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Product Type, Application and Specification
6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Business Overview
6.2 Stratatech Corporation
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Product Type, Application and Specification
6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Business Overview
6.3 Fibrocell Science, Inc.
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Product Type, Application and Specification
6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Business Overview
6.4 GlaxoSmithKline Plc
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Product Type, Application and Specification
6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Business Overview
6.5 InMed Pharmaceuticals Inc.
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Product Type, Application and Specification
6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Business Overview
6.6 Karus Therapeutics Limited
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Business Overview
6.7 RegeneRx Biopharmaceuticals, Inc.
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Product Type, Application and Specification
6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Business Overview
6.8 Scioderm, Inc.
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Business Overview
6.9 Shire Plc
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Product Type, Application and Specification
6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Business Overview
CHAPTER 7 DIABETIC MACULAR EDEMA MANUFACTURING COST ANALYSIS
7.1 Diabetic Macular Edema Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Diabetic Macular Edema
CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Diabetic Macular Edema Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Diabetic Macular Edema Major Manufacturers in 2016
8.4 Downstream Buyers
CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
CHAPTER 11 UNITED STATES DIABETIC MACULAR EDEMA MARKET FORECAST (2017-2022)
11.1 United States Diabetic Macular Edema Production, Revenue Forecast (2017-2022)
11.2 United States Diabetic Macular Edema Production, Consumption Forecast by Regions (2017-2022)
11.3 United States Diabetic Macular Edema Production Forecast by Type (2017-2022)
11.4 United States Diabetic Macular Edema Consumption Forecast by Application (2017-2022)
11.5 Diabetic Macular Edema Price Forecast (2017-2022)
CHAPTER 12 APPENDIX
1.1 Product Overview and Scope of Diabetic Macular Edema
1.2 Diabetic Macular Edema Market Segmentation by Type
1.2.1 United States Production Market Share of Diabetic Macular Edema by Type in 2016
1.2.1 Type
1.2.2 Type
1.2.3 Type
1.3 Diabetic Macular Edema Market Segmentation by Application
1.3.1 Diabetic Macular Edema Consumption Market Share by Application in 2016
1.3.2 Application
1.3.3 Application
1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Diabetic Macular Edema (2011-2021)
CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON DIABETIC MACULAR EDEMA INDUSTRY
2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend
CHAPTER 3 UNITED STATES DIABETIC MACULAR EDEMA MARKET COMPETITION BY MANUFACTURERS
3.1 United States Diabetic Macular Edema Production and Share by Manufacturers (2015 and 2016)
3.2 United States Diabetic Macular Edema Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Diabetic Macular Edema Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Diabetic Macular Edema Manufacturing Base Distribution, Production Area and Product Type
3.5 Diabetic Macular Edema Market Competitive Situation and Trends
3.5.1 Diabetic Macular Edema Market Concentration Rate
3.5.2 Diabetic Macular Edema Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
CHAPTER 4 UNITED STATES DIABETIC MACULAR EDEMA PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 United States Diabetic Macular Edema Production and Market Share by Type (2012-2017)
4.2 United States Diabetic Macular Edema Revenue and Market Share by Type (2012-2017)
4.3 United States Diabetic Macular Edema Price by Type (2012-2017)
4.4 United States Diabetic Macular Edema Production Growth by Type (2012-2017)
CHAPTER 5 UNITED STATES DIABETIC MACULAR EDEMA MARKET ANALYSIS BY APPLICATION
5.1 United States Diabetic Macular Edema Consumption and Market Share by Application (2012-2017)
5.2 United States Diabetic Macular Edema Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
5.3.1 Potential Applications
5.3.2 Emerging Markets/Countries
CHAPTER 6 UNITED STATES DIABETIC MACULAR EDEMA MANUFACTURERS ANALYSIS
6.1 Birken AG
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Product Type, Application and Specification
6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Business Overview
6.2 Stratatech Corporation
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Product Type, Application and Specification
6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Business Overview
6.3 Fibrocell Science, Inc.
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Product Type, Application and Specification
6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Business Overview
6.4 GlaxoSmithKline Plc
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Product Type, Application and Specification
6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Business Overview
6.5 InMed Pharmaceuticals Inc.
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Product Type, Application and Specification
6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Business Overview
6.6 Karus Therapeutics Limited
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Business Overview
6.7 RegeneRx Biopharmaceuticals, Inc.
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Product Type, Application and Specification
6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Business Overview
6.8 Scioderm, Inc.
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Business Overview
6.9 Shire Plc
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Product Type, Application and Specification
6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Business Overview
CHAPTER 7 DIABETIC MACULAR EDEMA MANUFACTURING COST ANALYSIS
7.1 Diabetic Macular Edema Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Diabetic Macular Edema
CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Diabetic Macular Edema Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Diabetic Macular Edema Major Manufacturers in 2016
8.4 Downstream Buyers
CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
CHAPTER 11 UNITED STATES DIABETIC MACULAR EDEMA MARKET FORECAST (2017-2022)
11.1 United States Diabetic Macular Edema Production, Revenue Forecast (2017-2022)
11.2 United States Diabetic Macular Edema Production, Consumption Forecast by Regions (2017-2022)
11.3 United States Diabetic Macular Edema Production Forecast by Type (2017-2022)
11.4 United States Diabetic Macular Edema Consumption Forecast by Application (2017-2022)
11.5 Diabetic Macular Edema Price Forecast (2017-2022)
CHAPTER 12 APPENDIX
LIST OF TABLES AND FIGURES
Figure Picture of Diabetic Macular Edema
Table Classification of Diabetic Macular Edema
Figure United States Sales Market Share of Diabetic Macular Edema by Type in 2016
Table Application of Diabetic Macular Edema
Figure United States Sales Market Share of Diabetic Macular Edema by Application in 2016
Figure United States Diabetic Macular Edema Sales and Growth Rate (2011-2021)
Figure United States Diabetic Macular Edema Revenue and Growth Rate (2011-2021)
Table United States Diabetic Macular Edema Sales of Key Manufacturers (2015 and 2016)
Table United States Diabetic Macular Edema Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Diabetic Macular Edema Sales Share by Manufacturers
Figure 2016 Diabetic Macular Edema Sales Share by Manufacturers
Table United States Diabetic Macular Edema Revenue by Manufacturers (2015 and 2016)
Table United States Diabetic Macular Edema Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Diabetic Macular Edema Revenue Share by Manufacturers
Table 2016 United States Diabetic Macular Edema Revenue Share by Manufacturers
Table United States Market Diabetic Macular Edema Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Diabetic Macular Edema Average Price of Key Manufacturers in 2015
Figure Diabetic Macular Edema Market Share of Top 3 Manufacturers
Figure Diabetic Macular Edema Market Share of Top 5 Manufacturers
Table United States Diabetic Macular Edema Sales by Type (2012-2017)
Table United States Diabetic Macular Edema Sales Share by Type (2012-2017)
Figure United States Diabetic Macular Edema Sales Market Share by Type in 2015
Table United States Diabetic Macular Edema Revenue and Market Share by Type (2012-2017)
Table United States Diabetic Macular Edema Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Diabetic Macular Edema by Type (2012-2017)
Table United States Diabetic Macular Edema Price by Type (2012-2017)
Figure United States Diabetic Macular Edema Sales Growth Rate by Type (2012-2017)
Table United States Diabetic Macular Edema Sales by Application (2012-2017)
Table United States Diabetic Macular Edema Sales Market Share by Application (2012-2017)
Figure United States Diabetic Macular Edema Sales Market Share by Application in 2016
Table United States Diabetic Macular Edema Sales Growth Rate by Application (2012-2017)
Figure United States Diabetic Macular Edema Sales Growth Rate by Application (2012-2017)
Table Birken AG Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Birken AG Diabetic Macular Edema Production, Revenue, Price and Gross Margin (2012-2017)
Table Birken AG Diabetic Macular Edema Market Share (2012-2017)
Table Stratatech Corporation Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Stratatech Corporation Diabetic Macular Edema Production, Revenue, Price and Gross Margin (2012-2017)
Table Stratatech Corporation Diabetic Macular Edema Market Share (2012-2017)
Table Fibrocell Science, Inc. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Fibrocell Science, Inc. Diabetic Macular Edema Production, Revenue, Price and Gross Margin (2012-2017)
Table Fibrocell Science, Inc. Diabetic Macular Edema Market Share (2012-2017)
Table GlaxoSmithKline Plc Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Plc Diabetic Macular Edema Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Plc Diabetic Macular Edema Market Share (2012-2017)
Table InMed Pharmaceuticals Inc. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table InMed Pharmaceuticals Inc. Diabetic Macular Edema Production, Revenue, Price and Gross Margin (2012-2017)
Table InMed Pharmaceuticals Inc. Diabetic Macular Edema Market Share (2012-2017)
Table Karus Therapeutics Limited Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Karus Therapeutics Limited Diabetic Macular Edema Production, Revenue, Price and Gross Margin (2012-2017)
Table Karus Therapeutics Limited Diabetic Macular Edema Market Share (2012-2017)
Table RegeneRx Biopharmaceuticals, Inc. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table RegeneRx Biopharmaceuticals, Inc. Diabetic Macular Edema Production, Revenue, Price and Gross Margin (2012-2017)
Table RegeneRx Biopharmaceuticals, Inc. Diabetic Macular Edema Market Share (2012-2017)
Table Scioderm, Inc. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Scioderm, Inc. Diabetic Macular Edema Production, Revenue, Price and Gross Margin (2012-2017)
Table Scioderm, Inc. Diabetic Macular Edema Market Share (2012-2017)
Table Shire Plc Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Shire Plc Diabetic Macular Edema Production, Revenue, Price and Gross Margin (2012-2017)
Table Shire Plc Diabetic Macular Edema Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Diabetic Macular Edema
Figure Manufacturing Process Analysis of Diabetic Macular Edema
Figure Diabetic Macular Edema Industrial Chain Analysis
Table Raw Materials Sources of Diabetic Macular Edema Major Manufacturers in 2016
Table Major Buyers of Diabetic Macular Edema
Table Distributors/Traders List
Figure United States Diabetic Macular Edema Production and Growth Rate Forecast (2017-2022)
Figure United States Diabetic Macular Edema Revenue and Growth Rate Forecast (2017-2022)
Table United States Diabetic Macular Edema Production Forecast by Type (2017-2022)
Table United States Diabetic Macular Edema Consumption Forecast by Application (2017-2022)
COMPANIES MENTIONED
Birken AG
Stratatech Corporation
Fibrocell Science, Inc.
GlaxoSmithKline Plc
InMed Pharmaceuticals Inc.
Karus Therapeutics Limited
RegeneRx Biopharmaceuticals, Inc..
Scioderm, Inc.
Shire Plc
Stratatech Corporation
Federal University of Sao Paulo
HaEmek Medical Center
The Cornea and Laser Eye Institute
Democritus University of Thrace
Isfahan University of Medical Sciences
Al-Noor Eye Hospital
Azienda Ospedaliera - Universitaria di Modena
Azienda Ospedaliera Universitaria Senese
Department of Health, South Africa
Emory University
Figure Picture of Diabetic Macular Edema
Table Classification of Diabetic Macular Edema
Figure United States Sales Market Share of Diabetic Macular Edema by Type in 2016
Table Application of Diabetic Macular Edema
Figure United States Sales Market Share of Diabetic Macular Edema by Application in 2016
Figure United States Diabetic Macular Edema Sales and Growth Rate (2011-2021)
Figure United States Diabetic Macular Edema Revenue and Growth Rate (2011-2021)
Table United States Diabetic Macular Edema Sales of Key Manufacturers (2015 and 2016)
Table United States Diabetic Macular Edema Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Diabetic Macular Edema Sales Share by Manufacturers
Figure 2016 Diabetic Macular Edema Sales Share by Manufacturers
Table United States Diabetic Macular Edema Revenue by Manufacturers (2015 and 2016)
Table United States Diabetic Macular Edema Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Diabetic Macular Edema Revenue Share by Manufacturers
Table 2016 United States Diabetic Macular Edema Revenue Share by Manufacturers
Table United States Market Diabetic Macular Edema Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Diabetic Macular Edema Average Price of Key Manufacturers in 2015
Figure Diabetic Macular Edema Market Share of Top 3 Manufacturers
Figure Diabetic Macular Edema Market Share of Top 5 Manufacturers
Table United States Diabetic Macular Edema Sales by Type (2012-2017)
Table United States Diabetic Macular Edema Sales Share by Type (2012-2017)
Figure United States Diabetic Macular Edema Sales Market Share by Type in 2015
Table United States Diabetic Macular Edema Revenue and Market Share by Type (2012-2017)
Table United States Diabetic Macular Edema Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Diabetic Macular Edema by Type (2012-2017)
Table United States Diabetic Macular Edema Price by Type (2012-2017)
Figure United States Diabetic Macular Edema Sales Growth Rate by Type (2012-2017)
Table United States Diabetic Macular Edema Sales by Application (2012-2017)
Table United States Diabetic Macular Edema Sales Market Share by Application (2012-2017)
Figure United States Diabetic Macular Edema Sales Market Share by Application in 2016
Table United States Diabetic Macular Edema Sales Growth Rate by Application (2012-2017)
Figure United States Diabetic Macular Edema Sales Growth Rate by Application (2012-2017)
Table Birken AG Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Birken AG Diabetic Macular Edema Production, Revenue, Price and Gross Margin (2012-2017)
Table Birken AG Diabetic Macular Edema Market Share (2012-2017)
Table Stratatech Corporation Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Stratatech Corporation Diabetic Macular Edema Production, Revenue, Price and Gross Margin (2012-2017)
Table Stratatech Corporation Diabetic Macular Edema Market Share (2012-2017)
Table Fibrocell Science, Inc. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Fibrocell Science, Inc. Diabetic Macular Edema Production, Revenue, Price and Gross Margin (2012-2017)
Table Fibrocell Science, Inc. Diabetic Macular Edema Market Share (2012-2017)
Table GlaxoSmithKline Plc Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Plc Diabetic Macular Edema Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Plc Diabetic Macular Edema Market Share (2012-2017)
Table InMed Pharmaceuticals Inc. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table InMed Pharmaceuticals Inc. Diabetic Macular Edema Production, Revenue, Price and Gross Margin (2012-2017)
Table InMed Pharmaceuticals Inc. Diabetic Macular Edema Market Share (2012-2017)
Table Karus Therapeutics Limited Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Karus Therapeutics Limited Diabetic Macular Edema Production, Revenue, Price and Gross Margin (2012-2017)
Table Karus Therapeutics Limited Diabetic Macular Edema Market Share (2012-2017)
Table RegeneRx Biopharmaceuticals, Inc. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table RegeneRx Biopharmaceuticals, Inc. Diabetic Macular Edema Production, Revenue, Price and Gross Margin (2012-2017)
Table RegeneRx Biopharmaceuticals, Inc. Diabetic Macular Edema Market Share (2012-2017)
Table Scioderm, Inc. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Scioderm, Inc. Diabetic Macular Edema Production, Revenue, Price and Gross Margin (2012-2017)
Table Scioderm, Inc. Diabetic Macular Edema Market Share (2012-2017)
Table Shire Plc Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Shire Plc Diabetic Macular Edema Production, Revenue, Price and Gross Margin (2012-2017)
Table Shire Plc Diabetic Macular Edema Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Diabetic Macular Edema
Figure Manufacturing Process Analysis of Diabetic Macular Edema
Figure Diabetic Macular Edema Industrial Chain Analysis
Table Raw Materials Sources of Diabetic Macular Edema Major Manufacturers in 2016
Table Major Buyers of Diabetic Macular Edema
Table Distributors/Traders List
Figure United States Diabetic Macular Edema Production and Growth Rate Forecast (2017-2022)
Figure United States Diabetic Macular Edema Revenue and Growth Rate Forecast (2017-2022)
Table United States Diabetic Macular Edema Production Forecast by Type (2017-2022)
Table United States Diabetic Macular Edema Consumption Forecast by Application (2017-2022)
COMPANIES MENTIONED
Birken AG
Stratatech Corporation
Fibrocell Science, Inc.
GlaxoSmithKline Plc
InMed Pharmaceuticals Inc.
Karus Therapeutics Limited
RegeneRx Biopharmaceuticals, Inc..
Scioderm, Inc.
Shire Plc
Stratatech Corporation
Federal University of Sao Paulo
HaEmek Medical Center
The Cornea and Laser Eye Institute
Democritus University of Thrace
Isfahan University of Medical Sciences
Al-Noor Eye Hospital
Azienda Ospedaliera - Universitaria di Modena
Azienda Ospedaliera Universitaria Senese
Department of Health, South Africa
Emory University
